Acute Porphyria Drug Database

Monograph

J02AX01 - Flucytosine
Propably not porphyrinogenic
PNP

Rationale
Given in gram doses but probably not significantly metabolised. No data pointing to CYP affinity. Four references state non-porphyrinogenicity.
Chemical description
Antimycotic pyrimidine derivative in systemic use (infusion of 1 g x 4) in sepsis, meningitis, endocarditis etc. Excreted mainly in unchanged form by the kidneys, small amounts converted to fluorouracil. No indications of CYP-interaction. Australian list: safe. EPI-list: safe. South African list: use. French list: use.
Similar drugs
Explore alternative drugs in similar therapeutic classes J02A / J02AX or go back.
Tradenames
This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.


Ancotil Ancotil · Flucytosine Ancotil · Flucytosine Ancotil
 
© NAPOS 2025
An unhandled error has occurred. Reload 🗙